3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
9
Lung Neoplasms
5
Fatigue
4
Trismus
3
Pain
3
Neoplasms
3
Lymphedema
3
Head and Neck Neoplasms
3
Prostatic Neoplasms
2
Peripheral Nervous System Diseases
2
Ovarian Neoplasms
2
Mouth Neoplasms
2
Motor Activity
2
Hematologic Neoplasms
2
Cachexia
2
Breast Neoplasms, Male
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Shoulder Pain
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Interventions
Cyclophosphamide
216
Methotrexate
140
Cytarabine
131
Vincristine
110
fludarabine phosphate
103
Peripheral Blood Stem Cell Transplantation
98
Filgrastim
92
Etoposide
92
Dexamethasone
89
Mycophenolic Acid
71
Doxorubicin
70
Whole-Body Irradiation
67
Mercaptopurine
66
Busulfan
65
Tacrolimus
64
Radiotherapy
63
Cyclosporine
62
Prednisone
55
Daunorubicin
53
pegaspargase
51
Asparaginase
51
Rituximab
48
fludarabine
47
Granulocyte Colony-Stimulating Factor
46
Melphalan
45
Antilymphocyte Serum
43
Clofarabine
42
Calcium Dobesilate
38
Methylprednisolone
36
Leucovorin
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Physical Therapy Modalities
×
Clear all
NCT00902213
2015-11-17
PAQOL
St. Jude Children's Research Hospital
Phase NA
Completed
122 enrolled